Company Filing History:
Years Active: 2012-2015
Title: Jon Gordon Selbo: Innovator in Pharmaceutical Chemistry
Introduction
Jon Gordon Selbo is a notable inventor based in Wentzville, MO (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. With a total of three patents to his name, Selbo's work is recognized for its potential impact on treating various conditions.
Latest Patents
Selbo's latest patents focus on crystalline forms of a p38 kinase inhibitor, specifically 3-[5-chloro-4-[(2,4-difluorobenzyl) oxy]-6-oxopyrimidin-1(6H)-yl]-N-(2-hydroxyethyl)-4-methylbenzamide. These patents provide detailed methods for the prophylaxis and treatment of p38 kinase-mediated conditions. The crystalline forms are designed to enhance the efficacy of the pharmaceutical compositions, offering new avenues for therapeutic interventions.
Career Highlights
Jon Gordon Selbo is currently associated with Pfizer Corporation, a leading global biopharmaceutical company. His role at Pfizer allows him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development in pharmaceuticals. His expertise in chemistry and innovation has positioned him as a valuable asset to the company.
Collaborations
Throughout his career, Selbo has worked alongside talented colleagues, including Edgardo Alvira and Matthew James Graneto. These collaborations have fostered an environment of creativity and innovation, leading to the successful development of new pharmaceutical solutions.
Conclusion
Jon Gordon Selbo's contributions to pharmaceutical chemistry through his innovative patents and collaborations at Pfizer Corporation highlight his commitment to advancing medical science. His work continues to pave the way for new treatments that can significantly improve patient outcomes.